JPS58188878A - メフロキンの精製方法 - Google Patents
メフロキンの精製方法Info
- Publication number
- JPS58188878A JPS58188878A JP58063823A JP6382383A JPS58188878A JP S58188878 A JPS58188878 A JP S58188878A JP 58063823 A JP58063823 A JP 58063823A JP 6382383 A JP6382383 A JP 6382383A JP S58188878 A JPS58188878 A JP S58188878A
- Authority
- JP
- Japan
- Prior art keywords
- mixture
- mefloquine
- hydrochloride
- methanol
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000746 purification Methods 0.000 title description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 51
- 239000000203 mixture Substances 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- WESWYMRNZNDGBX-YLCXCWDSSA-N Mefloquine hydrochloride Chemical compound Cl.C([C@@H]1[C@@H](O)C=2C3=CC=CC(=C3N=C(C=2)C(F)(F)F)C(F)(F)F)CCCN1 WESWYMRNZNDGBX-YLCXCWDSSA-N 0.000 claims description 16
- 229960005329 mefloquine hydrochloride Drugs 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 12
- 230000004048 modification Effects 0.000 claims description 10
- 238000012986 modification Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 238000005984 hydrogenation reaction Methods 0.000 claims description 2
- PCSUEZZVJSFJOC-UHFFFAOYSA-N [2-(trifluoromethyl)quinolin-4-yl]methanol;hydrochloride Chemical compound Cl.C1=CC=C2C(CO)=CC(C(F)(F)F)=NC2=C1 PCSUEZZVJSFJOC-UHFFFAOYSA-N 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000002035 prolonged effect Effects 0.000 claims 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- XEEQGYMUWCZPDN-DOMZBBRYSA-N (-)-(11S,2'R)-erythro-mefloquine Chemical compound C([C@@H]1[C@@H](O)C=2C3=CC=CC(=C3N=C(C=2)C(F)(F)F)C(F)(F)F)CCCN1 XEEQGYMUWCZPDN-DOMZBBRYSA-N 0.000 description 8
- 238000002329 infrared spectrum Methods 0.000 description 7
- 229960001962 mefloquine Drugs 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical group O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- GIZSHQYTTBQKOQ-UHFFFAOYSA-N threo-Syringoylglycerol Chemical compound COC1=CC(C(O)C(O)CO)=CC(OC)=C1O GIZSHQYTTBQKOQ-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- -1 quinolyl ketone Chemical class 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GZTUXOWPGYDWNO-UHFFFAOYSA-N [2,8-bis(trifluoromethyl)quinolin-4-yl]-pyridin-2-ylmethanone Chemical compound C=12C=CC=C(C(F)(F)F)C2=NC(C(F)(F)F)=CC=1C(=O)C1=CC=CC=N1 GZTUXOWPGYDWNO-UHFFFAOYSA-N 0.000 description 2
- 150000001721 carbon Chemical class 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 230000029052 metamorphosis Effects 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- KXYNLLGPBDUAHW-UHFFFAOYSA-N quinolin-4-ylmethanol Chemical compound C1=CC=C2C(CO)=CC=NC2=C1 KXYNLLGPBDUAHW-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- QCSGLAMXZCLSJW-UHFFFAOYSA-L platinum(2+);diacetate Chemical compound [Pt+2].CC([O-])=O.CC([O-])=O QCSGLAMXZCLSJW-UHFFFAOYSA-L 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- CSRDQUAKBOCNGV-UHFFFAOYSA-N quinolin-2-ylmethanol;hydrochloride Chemical compound Cl.C1=CC=CC2=NC(CO)=CC=C21 CSRDQUAKBOCNGV-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH225682 | 1982-04-14 | ||
| CH2256/829 | 1982-04-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58188878A true JPS58188878A (ja) | 1983-11-04 |
| JPH0127070B2 JPH0127070B2 (cg-RX-API-DMAC7.html) | 1989-05-26 |
Family
ID=4229522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58063823A Granted JPS58188878A (ja) | 1982-04-14 | 1983-04-13 | メフロキンの精製方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4507482A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0092185B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPS58188878A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE33647T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE3376320D1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE55387T1 (de) * | 1983-10-07 | 1990-08-15 | Hoffmann La Roche | Mefloquin-hydrochlorid. |
| HUT54363A (en) * | 1989-07-25 | 1991-02-28 | Alkaloida Vegyeszeti Gyar | Process for producing pyridyl-methyl-quinolin derivatives |
| US20030216426A1 (en) * | 2002-05-17 | 2003-11-20 | Regents Of The University Of California | Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogs |
| EP2233481A1 (de) | 2009-03-27 | 2010-09-29 | Cilag Ltd. | Verfahren zur Herstellung von Mefloquin |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53103478A (en) * | 1977-02-17 | 1978-09-08 | Hoffmann La Roche | Method of producing erythro alphaa22piperidyl 2*88bis*trifluoromethyl**44quinolinemethanol |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2940443A1 (de) * | 1979-10-05 | 1981-04-16 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von erythro-(alpha)-2-piperidyl-2,8-bis-(trifluormethyl)-4-chinolin-methanol |
-
1983
- 1983-04-04 US US06/481,691 patent/US4507482A/en not_active Expired - Lifetime
- 1983-04-13 JP JP58063823A patent/JPS58188878A/ja active Granted
- 1983-04-14 EP EP83103632A patent/EP0092185B1/de not_active Expired
- 1983-04-14 DE DE8383103632T patent/DE3376320D1/de not_active Expired
- 1983-04-14 AT AT83103632T patent/ATE33647T1/de not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53103478A (en) * | 1977-02-17 | 1978-09-08 | Hoffmann La Roche | Method of producing erythro alphaa22piperidyl 2*88bis*trifluoromethyl**44quinolinemethanol |
Also Published As
| Publication number | Publication date |
|---|---|
| US4507482A (en) | 1985-03-26 |
| JPH0127070B2 (cg-RX-API-DMAC7.html) | 1989-05-26 |
| EP0092185A3 (en) | 1985-07-03 |
| DE3376320D1 (en) | 1988-05-26 |
| EP0092185A2 (de) | 1983-10-26 |
| ATE33647T1 (de) | 1988-05-15 |
| EP0092185B1 (de) | 1988-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4112032B2 (ja) | Ｎ−［３−（３−シアノピラゾロ［１，５−ａ］ピリミジン−７−イル）フェニル］−Ｎ−エチル−アセトアミドの改良された製造方法 | |
| JPH0643400B2 (ja) | トラセミドの安定な変態の製法 | |
| TWI518072B (zh) | 塔適那偉（ａｔａｚａｎａｖｉｒ）硫酸氫鹽之製法及其新穎的形式 | |
| JPS58188878A (ja) | メフロキンの精製方法 | |
| CN1980666B (zh) | 制备阿扎那韦硫酸氢盐的方法和新的形式 | |
| JPH04225975A (ja) | Ｎ−［３−（１ｈ−イミダゾール−１−イル）フエニル］−４−（置換）−２−ピリミジナミン合成の改良法 | |
| JP4311901B2 (ja) | 複素環誘導体 | |
| CN112010774A (zh) | FXIa凝血因子抑制剂、其药物组合物和用途 | |
| JPH02124885A (ja) | イミダゾール抗不整脈剤 | |
| US4851420A (en) | 2,6-diamino-3-halobenzylpyridines and processes for their manufacture as well as their use in pharmaceuticals | |
| JPH0570461A (ja) | イソキノリン化合物の製造法 | |
| US4533735A (en) | Process for preparing antibacterial compounds | |
| US3939172A (en) | 4-Aminothiazole | |
| US4579855A (en) | Melfloquin hydrochloride | |
| AU627609B2 (en) | New quinoline derivatives and process for the preparation thereof | |
| WO1991001315A1 (en) | New quinoline derivatives and process for the preparation thereof | |
| CN119591481A (zh) | 一种合成泊沙康唑中间体(2s)-2-苄氧基-3-戊酮的方法 | |
| JPS638385A (ja) | 化合物の製造方法 | |
| US4011210A (en) | 4-sulfanilamidothiazole | |
| CN107365299B (zh) | 一种达比加群酯的制备方法及其中间体 | |
| JPH0532629A (ja) | 高純度メチルチオカーバメイト類の製造方法 | |
| JP3281492B2 (ja) | Ｎ−ヒドロキシウレア類 | |
| JP2003081971A (ja) | ５−ピリジルメチルヒダントイン化合物及びｎ−カルバモイル−３−（ピリジル）アラニン化合物 | |
| JPH08291140A (ja) | 易吸収性結晶 | |
| JPS63222162A (ja) | プテノライド誘導体とその製造法 |